Evidence map›Paper›PMID 38414627›Full record

ReviewBiomedical reports2024

Role of

Ángeles Torres-Valdetano, Verónica Vallejo-Ruiz, Lorena Milflores-Flores, Patricia Martínez-Morales

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedical reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ángeles Torres-ValdetanoFaculty of Biological Science, Building BIO 1 University City, Autonomous University of Puebla, Puebla 72570, Mexico.
Verónica Vallejo-RuizMexican Social Security Institute, East Biomedical Research Center, Puebla 74360, Mexico.
Lorena Milflores-FloresFaculty of Biological Science, Building BIO 1 University City, Autonomous University of Puebla, Puebla 72570, Mexico.
Patricia Martínez-MoralesNational Council of Humanities, Sciences and Technologies, East Biomedical Research Center, Puebla 74360, Mexico.
Benemérita Universidad Autónoma de Puebla · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylphosphatidylinositol-glycan (GPI) is an anchor to specific cell surface proteins known as GPI-anchored proteins (APs) that are localized in lipid rafts and may act as cell co-receptors, enzymes and adhesion molecules. The present review investigated the significance of GPI biosynthesis class phosphatidylinositol-glycan

Indexed as

cancerglycosylphosphatidylin-ositolglycosylphosphatidylinositol-anchored proteinGPI-mannosyltransferase Ihyperphosphatasia with mental retardation syndromeparasitic diseaseparoxysmal nocturnal hemoglobinuriaPIGMPIGX

Identifiers

PMID38414627
PMCPMC10895387
OpenAlexW4391535878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.